 | | April 20, 2010 • Volume 7 / Number 8 | The latest issue of the NCI Cancer Bulletin is now available at http://www.cancer.gov/ncicancerbulletin. Keep up to date on the latest research and advances in the prevention, treatment, and understanding of cancer.
- Long-term Follow-up Confirms Breast Cancer Risk Reduction with Raloxifene »
- MicroRNAs Linked to Trastuzumab Resistance, Brain Metastases »
- Diabetes Drug Metformin Prevents Lung Tumors in Mice »
- Cancer Risk Tools May Need Regular Recalibration »
- Profiling Airway Cells May Identify Smokers at Highest Risk of Cancer »
- Peptide Helps Chemotherapy Penetrate Deep into Tumors »
- Director's Update: An Unexpected Opportunity, a Welcome Honor »
- Guest Commentary by Dr. Carolyn Clancy: Focusing the Research Enterprise on the Patient »
- Trial Makes Push Toward More Individualized Lung Cancer Therapy »
- Genome Study of Aggressive Breast Cancer Yields Clues to Metastasis »
- Featured Clinical Trial: Pioglitazone for Oral Premalignant Lesions »
- IoM Committee Recommends Overhaul of NCI Clinical Trials Cooperative Group Program »
- FDA Update »
- Legislative Update »
- Cancer.gov Update »
- Notes »
|
Posts
No comments:
Post a Comment